Table 3 Antibiotic susceptibility profile of isolates
From: Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana
Antibiotics | Total number of isolates (N) | Susceptible N (%) | Intermediate N (%) | Resistant N (%) |
|---|---|---|---|---|
Ampicillin | 162 | 7 (4.3) | 2 (1.2) | 153 (94.4) |
Amox/clav | 200 | 51 (25.5) | 47 (23.5) | 102 (51.5) |
Piperacillin-tazobactam | 198 | 109 (54.5) | 62 (31.0) | 27 (13.5) |
Cefuroxime | 200 | 35 (17.5) | 7 (3.5) | 158 (79.0) |
Cefoxitin | 200 | 74 (37.0) | 11 (5.5) | 115 (57.5) |
Cefotaxime | 199 | 44 (22.1) | 12 (6.0) | 143 (71.3) |
Ceftazidime | 200 | 104 (52.0) | 15 (7.5) | 81 (40.5) |
Cefepime | 200 | 119 (59.5) | 64 (32.0) | 17 (8.5) |
Ertapenam | 132 | 130 (98.5) | 1 (0.8) | 1 (0.8) |
Imipenem | 199 | 191 (95.5) | 0 (0.0) | 8 (4.0) |
Meropenem | 198 | 192 (97.0) | 1 (0.5) | 5 (2.5) |
Amikacin | 199 | 178 (89.4) | 14 (7.0) | 7 (3.5) |
Gentamicin | 198 | 105 (53.0) | 5 (2.5) | 88 (44.4) |
Ciprofloxacin | 200 | 116 (58.0) | 2 (1.0) | 82 (41.0) |
Tetracycline | 199 | 124 (62.3) | 14 (7.0) | 61 (30.7) |
Nitrofuratoin | 200 | 84 (42.0) | 17 (8.5) | 99 (49.5) |
Collistin | 198 | 164 (82.8) | 2 (1.0) | 32 (16.2) |
Trim/Sulfamethoxazole | 200 | 31 (15.5) | 0 (0.0) | 169 (84.5) |